Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $34,439 | $34,439 | $39,607 | $39,311 |
| - Cash | $10,516 | $10,882 | $7,452 | $6,651 |
| + Debt | $10,490 | $10,586 | $9,159 | $9,282 |
| Enterprise Value | $34,413 | $34,143 | $41,314 | $41,941 |
| Revenue | $5,389 | $21,859 | $6,237 | $3,873 |
| % Growth | -75.3% | 250.5% | 61% | – |
| Gross Profit | $3,663 | $14,617 | $4,313 | $2,573 |
| % Margin | 68% | 66.9% | 69.1% | 66.4% |
| EBITDA | -$1,234 | -$14,595 | $872 | -$785 |
| % Margin | -22.9% | -66.8% | 14% | -20.3% |
| Net Income | -$2,670 | -$7,904 | -$60 | -$1,569 |
| % Margin | -49.5% | -36.2% | -1% | -40.5% |
| EPS Diluted | -0.23 | -0.68 | -0.005 | -0.12 |
| % Growth | 66.2% | -15,011.1% | 96.2% | – |
| Operating Cash Flow | -$449 | -$4,250 | – | – |
| Capital Expenditures | -$64 | -$36 | – | – |
| Free Cash Flow | -$513 | -$4,287 | – | – |